Explore

Trendline Trendline
Stoke Therapeutics to Present at Needham Virtual Healthcare Conference

Stoke Therapeutics to Present at Needham Virtual Healthcare Conference

Stoke Therapeutics to Present at Needham Virtual Healthcare Conference
Trendline Trendline
Kelun-Biotech Gains Approval to Remove 'B' Marker, Signifying New Development Stage

Kelun-Biotech Gains Approval to Remove 'B' Marker, Signifying New Development Stage

Kelun-Biotech Gains Approval to Remove 'B' Marker, Signifying New Development Stage
Trendline Trendline
Sensei Biotherapeutics to Present at Needham Virtual Healthcare Conference

Sensei Biotherapeutics to Present at Needham Virtual Healthcare Conference

Sensei Biotherapeutics to Present at Needham Virtual Healthcare Conference
Trendline Trendline
Viking Therapeutics to Engage with Investors at Upcoming Conferences

Viking Therapeutics to Engage with Investors at Upcoming Conferences

Viking Therapeutics to Engage with Investors at Upcoming Conferences
Trendline Trendline
Viking Therapeutics to Present at Key Investor Conferences

Viking Therapeutics to Present at Key Investor Conferences

Viking Therapeutics to Present at Key Investor Conferences
Trendline Trendline
KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments

KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments

KalVista Pharmaceuticals to Present at Needham Virtual Healthcare Conference, Highlighting Rare Disease Treatments
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference on New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference on New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference on New Therapies
Trendline Trendline
Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at Virtual Healthcare Conference
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Trendline Trendline
Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities
Trendline Trendline
ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury

ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury

ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury